April 21 (Reuters) - Swedish medical equipment maker Getinge reported a bigger than expected drop in first-quarter core earnings on Tuesday, citing a decline in ventilator sales and lower investments ...

Despite currency and tariff challenges, Getinge AB (GNGBY) reports solid cash flow and strategic product launches to bolster future growth.

"We succeeded in surpassing last year's record-breaking first quarter with organic growth in both net sales and order intake," says Mattias Perjos, President & CEO at Getinge. The medtech company's ...

Swedish medical equipment maker Getinge reported an 18% decline in first-quarter adjusted EBITA on Tuesday, missing analyst ...

Narrow-moat Getinge GETI B reported third-quarter earnings above our expectations. We are increasing our fair value estimate to SEK 247 from SEK 221, as Getinge is executing a turnaround in its acute ...

Several years into the process of rectifying potential breaches in the sterile packaging of its life support systems—a process that has been littered with field correction notices and FDA-rated ...

Philips and Getinge aim to combine their respective equipment for patient monitoring and delivering anesthesia into a single workstation, with the goal of simplifying operations in the operating room.

The latest collection of health news includes EU approval for Moderna's combined flu and COVID shot, psychedelic drug shares soaring due to U.S. policy changes, and legal challenges affecting U.S.

GETINGE, Sweden--(BUSINESS WIRE)--Regulatory News: Getinge Group (STO:GETIB) has recently performed a strategic review to clarify its long-term strategy for ensuring sustainable and profitable growth.

Press release Gothenburg, Sweden on April 21, 2026 "We succeeded in surpassing last year's record-breaking first quarter with organic growth in both net sales and order intake," says Mattias Perjos, P ...